NOVN · Novartis AG
126.90
CHFUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
Fr259.77B
PE
18.30
EV/EBITDA
12.6
DIV Yield
3.4%
Payout Ratio
62%
MQV Rating
2Strong
As at 24/07/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- All-Consensus
- ALL-Recommendations
- HALO 100
- HALO 200
- HALO 50
- HALO All
- HALO Capital Efficiency
- Hammer Bearish (Realtime)
- Near Resistance
- Near Resistance (Realtime)
- Short Term Trend - Long
Key Fundamentals
EPS 3 yr Growth
126.20%
EBITDA Margin
40.90%
Operating Cashflow
$19,144m
Free Cash Flow Return
26.30%
ROIC
19.20%
Interest Coverage
18.90
Quick Ratio
0.90
Performance
52 weeks range
Low 91.56 - 131
Trade Value (12mth)
US$99,327,531.00
1 week
3.57%
1 month
1.32%
YTD
17.66%
1 year
38.53%
All time high
131.00
Additional Data
Shares Outstanding (Fully Diluted)
1,914m
HALO Sector
Healthcare
Next Company Report Date
03-Feb-27
Next Ex Dividend Date
10-Mar-26
Next Dividend Pay Date
12-Mar-26
Reporting Currency
USD
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Very Strong
Event
Very Strong
Halo Model
Mqv
Strong
Garp
Neutral
Mqv Small
Neutral
Momentum
Price
Strong
Earnings
Strong
Growth
Earnings
Neutral
Dividends
Very Weak
Quality
Capital Efficiency
Very Strong
Balance Sheet
Weak
Valuation
Value
Consensus
Yield
News & Announcements
| Date | Event |
18 July 25Flash | |
30 April 25Flash | |
30 October 24Flash | |
23 September 24Flash | |
22 September 24Flash |
